KRT6A expression was significantly increased in rosacea lesions and positively correlated with Investigator’s Global Assessment (IGA) scores but not with Clinical Erythema Assessment (CEA) scores (Fig. 1B, C and Supplementary Fig. 1B), indicating its involvement in inflammation. Here, KRT6A is linked to rosacea.